Article
Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia-reperfusion injury via upregulation of splenic regulatory T cells.
BMC cardiovascular disorders - 27 Apr 2021
Pang Ling-Xiao, Cai Wen-Wei, Li Qian, Li Heng-Jie, Fei Min, Yuan Yong-Sheng, Sheng Bin, Zhang Ke, An Rong-Cheng, Ou Ying-Wei, Zeng Wen-Jie
Abstract excerpt
BACKGROUND: Myocardial ischemia-reperfusion injury (MIRI) is the main pathological manifestation of cardiovascular diseases such as myocardial infarction. The potential therapeutic effects of bone marrow-derived mesenchymal stem cells (BM-MSCs) and the participation of regulatory T cells (Tregs) in MIRI remains to be defined. METHODS: We used the experimental acute MIRI that was induced in mice by left ascending...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
